Sumitomo Chemical India

    SUMICHEM
    Chemicals
    ₹334.25
    Price as of 18 Nov 2026, 9:58 pm IST

    Market cap ₹16,684 Cr

    P/E
    29.84
    Day range
    ₹330.50 – ₹341.70
    52-week range
    ₹310.85 – ₹572.05
    Volume
    2.53 L
    Open
    ₹340.00
    Prev close
    ₹342.40

    Latest results · Q2 FY27(consolidated)Revenue ₹907 Cr-2.4%Profit ₹157 Cr-11.5%Margin 17.3%YoY vs the same quarter last year

    No red flags in exchange filings: no rising pledge, promoter selling, surveillance or critical filing on record.

    Research profile

    Composite 42 / 100

    Factor percentiles

    Value55
    Quality65
    Momentum11
    Low volatility36

    Derived metrics

    Earn. yield
    3.4%
    Graham no.
    ₹134.08
    vs Graham
    -59.9%
    ROE ÷ P/B
    3.7%
    12-1 mom.
    -14.4%
    Return / vol
    -0.82
    Magic Formula
    #176
    Piotroski
    3/6
    FCF yield
    2.3%

    Percentiles rank this stock against the other tracked stocks and change as they do. Scans describe where figures sit today. Hover a label for its definition. Not investment advice.

    Peer comparison

    All 44 in Chemicals
    Largest Chemicals companies tracked, with sector medians
    CompanyM-capP/EP/BROEROCEOPMD/ESales YoY
    Solar IndustriesSOLARINDS₹1.68 L Cr74.0422.1932.5%38.0%29.0%0.23+69.0%
    Pidilite IndustriesPIDILITIND₹1.56 L Cr58.1214.0524.0%31.0%20.0%0.03+20.9%
    SRF LtdSRF₹72,471 Cr31.754.8013.8%15.0%19.0%0.35+34.7%
    Linde IndiaLINDEINDIA₹58,548 Cr118.4613.4213.6%18.0%32.0%0.23+12.3%
    Coromandel InternationalCOROMANDEL₹57,701 Cr37.014.3016.1%22.0%9.0%0.12+6.6%
    Gujarat FluorochemicalsFLUOROCHEM₹52,952 Cr78.396.177.6%10.0%27.0%0.28+45.5%
    Navin Fluorine InternationalNAVINFLUOR₹52,759 Cr57.9511.3720.1%21.0%34.0%0.28+57.1%
    Sumitomo Chemical IndiaSUMICHEM₹16,684 Cr29.844.6217.3%22.0%20.0%0.02-2.5%
    Sector median₹13,505 Cr31.752.869.9%12.0%15.7%0.27+21.5%

    Sector as classified in the tracked universe; medians use every tracked Chemicals company, and P/E only profitable ones. Tinted figures beat the median.

    Latest news

    Updated 20h ago

    Headlines about Sumitomo Chemical India from the last two weeks in the financial press. Stories belong to their publishers; Rajat Finance does not endorse them.

    Key metrics

    P/E (TTM)
    31.0
    Price / Book
    4.51
    ROE (FY26)
    17.3%
    ROCE (latest year)
    22%
    Dividend yield
    0.38%

    Moving averages (NSE)

    20-day
    ₹341.23
    Price below
    50-day
    ₹401.21
    Price below
    200-day
    ₹444.14
    Price below

    Charts & trends

    From company filings. Amounts in ₹ crore.

    Revenue 3Y CAGR
    -2.7%
    Profit 3Y CAGR
    +2.7%
    Revenue YoY (Sep 2026)
    -2.5%
    Profit YoY (Sep 2026)
    -11.8%
    Operating margin
    20.0%
    Net margin
    17.3%

    Revenue, profit & margin - quarterly

    ₹ crore; a loss shows red. Operating margin below, same periods.

    0 Cr500 Cr1K Cr1.5K Cr
    • Revenue
    • Net profit

    Operating margin

    Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Sep 20260%15%30%

    Who owns the company

    % of equity by quarter, latest Sept 2026

    Dec '24Mar '25Jun '25Sept '25Dec '25Mar '26Jun '26Sept '260%25%50%75%100%
    • Promoter
    • Public
    • DII
    • FII

    Cash flows

    Where cash came from and went, by fiscal year (₹ crore)

    Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026-500 Cr0 Cr500 Cr1K Cr
    • Operating
    • Investing
    • Financing
    • Free cash flow

    Return on equity

    Net profit over shareholders' equity, by fiscal year

    FY17FY18FY19FY20FY21FY22FY23FY24FY25FY260%10%20%30%15% screen

    Equity vs debt

    Shareholders' equity against borrowings (₹ crore); the ratio below, same years.

    0 Cr1K Cr2K Cr3K Cr4K Cr
    • Equity
    • Debt

    Debt to equity

    Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 20260x0.5x1x

    Dividends per share

    ₹ by fiscal year of the ex-date; the latest year runs to date.

    FY22FY23FY24FY25FY26FY27₹0₹2₹4₹6₹8

    Financial statements

    ₹ Crore
    Quarterly results, oldest period first, figures in rupees crore
    Line itemDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
    Sales5426748399886426791,0579305686841,063907
    YoY Sales growth-28——————-6-12——-2
    Expenses476534678743536560838712468550830722
    Operating Profit6614016124510612021921899134233186
    OPM %12%21%19%25%17%18%21%23%18%20%22%20%
    Other Income272726313132393921327444
    Interest111122222222
    Depreciation161715161916161717171717
    Profit before tax75149171260117133241238102148288210
    Tax %27%26%26%26%25%25%26%25%25%25%26%25%
    Net Profit551101271938710017817876111215157
    EPS in Rs₹1.10₹2.20₹2.54₹3.85₹1.74₹2.00₹3.57₹3.56₹1.52₹2.23₹4.30₹3.15

    From company filings, updated 18 Nov 2026. Consolidated figures where the company reports them. Information only, not investment advice.

    Working-capital cycle

    Debtor Days83

    -34 days since Mar 2021

    Inventory Days166

    -19 days since Mar 2021

    Days Payable86

    -59 days since Mar 2021

    Cash Conversion Cycle163

    +6 days since Mar 2021

    Working Capital Days154

    +59 days since Mar 2021

    Strengths, risks & growth

    Sumitomo Chemical India Ltd. (SCIL) is one of the leading players in the industry which has a balanced portfolio of technical as well as formulation products along with backward integration for some products. The Company is known for domestic marketing of proprietary products of its Japanese parent -Sumitomo Chemical Company Limited in agrochemicals, animal nutrition, and environmental health business segments. With the integration of Excel Crop Care Limited, the Company now has a strong portfolio of generics in addition to specialty products and a strong combined marketing network. With this integration, the Company has moved up several notches in the pecking order of the Indian crop protection industry. SCIL has also marked its presence in Africa and several other geographies of the world. [1] [2]

    Strengths

    • Company is almost debt free.
    • Company has been maintaining a healthy dividend payout of 34.5%

    Risks

    • The company has delivered a poor sales growth of 4.13% over past five years.

    Compounded Sales Growth

    10 Years
    —
    5 Years
    +4%
    3 Years
    -3%
    TTM
    -3%

    Compounded Profit Growth

    10 Years
    —
    5 Years
    +8%
    3 Years
    +2%
    TTM
    +2%

    Stock Price CAGR

    10 Years
    —
    5 Years
    -2%
    3 Years
    -4%
    1 Year
    -26%

    Return on Equity

    10 Years
    —
    5 Years
    +19%
    3 Years
    +16%
    Last Year
    +16%

    Strengths and risks are a machine-generated checklist, not advice; growth is compounded annually over each period.

    Shareholding pattern

    Percentage of shares held by each category at each quarter end
    HolderDec 2025Mar 2026Jun 2026Sept 2026Change
    Promoter75.00%75.00%75.00%75.00%0.00 pp
    FII3.37%3.41%3.02%2.89%-0.13 pp
    DII8.65%8.98%9.33%9.68%+0.35 pp
    Public12.97%12.60%12.65%12.42%-0.23 pp

    Filed with NSE for Sept 2026: promoters 75.00%, public 25.00%

    Analysts & fund holdings

    89%
    89% recommend buy
    9 analysts cover the stock
    Valuation vs Chemicals
    P/E29.8 vs 24.8
    Sector P/B2.98
    Beta0.65

    Who holds the shares, quarter by quarter

    Mutual funds 7.68% (+0.41 pp)
    Jun 25
    Sept 25
    Dec 25
    Mar 26
    Jun 26
    Sept 26
    • Promoters75.0%
    • Foreign institutions2.9%
    • Mutual funds7.7%
    • Insurance0.8%
    • Other domestic institutions1.2%
    • Retail6.2%
    • Others6.3%
    Mutual funds holding the most
    Fund% of company% of fund3-month change
    Aditya Birla SL Flexi Cap Fund0.87%0.53%-0.29 pp
    Nippon India Small Cap Fund0.84%0.19%-0.04 pp
    HSBC Small Cap Fund0.83%0.82%-0.52 pp
    Aditya Birla SL ELSS Tax Saver Fund0.68%0.86%-0.22 pp
    Edelweiss Mid Cap Fund0.58%0.53%-0.31 pp

    Scorecard

    Performance
    Low
    Valuation
    High
    Growth
    Low
    Profitability
    High
    Entry point
    Good
    Red flags
    Low

    Analyst coverage, holdings and scorecard from market data; not a recommendation by Rajat Finance.

    Risk & trend

    From 292 daily sessions to 18 Nov 2026.

    Computed

    Risk

    Volatility (1Y)
    35.6%
    Downside volatility
    32.5%
    Worst 5% of days
    3.6%
    Average of that tail
    4.3%
    Max drawdown (1Y)
    47.8%
    Below its peak
    44.5%

    Against the market

    Beta vs Nifty 50
    1.10
    Correlation
    0.42
    Relative strength (3M)
    -44.2%
    ATR (14)
    4.1%

    Return

    Return 1M
    -17.4%
    Return 3M
    -40.3%
    Return 6M
    -25.7%
    Return 1Y
    -29.3%
    vs 200-day average
    -24.7%

    Momentum

    RSI (14)
    34.9
    MACD histogram
    5.12
    Stochastic %K
    44.6
    ADX (14)
    40.9
    +DI / −DI
    17.7 / 31.4
    Money flow index
    47.7

    Participation

    Delivery (20d avg)
    50.7%
    vs its 60-day baseline
    -0.1 pts
    Volume vs 20-day
    -0.8σ
    Close vs day's VWAP
    -0.1%
    52-week position
    7 / 100

    These describe what this stock's price has already done. They are not forecasts, signals or recommendations, and a dash means the figure was withheld for want of enough history rather than being zero.

    Financial quality

    From consolidated statements to 30 Sept 2026.

    Computed

    Piotroski F-Score

    3 of 6 tested

    • Return on assets positive — passed
    • Operating cash flow positive — not testableno cash flow statement for this period
    • Return on assets improving — failed
    • Cash flow exceeds profit — not testableneeds cash flow and profit against assets
    • Debt to assets falling — failed
    • Current ratio improving — passed
    • No new equity issued — not testableno share count is collected, and financing cash flow mixes equity with debt
    • Operating margin improving — passed
    • Asset turnover improving — failed
    Free cash flow
    ₹401 Cr
    FCF yield
    2.3%
    Cash conversion
    0.82
    Accruals ratio
    0.022
    Net debt
    ₹4 Cr
    Net debt / equity
    0.00
    EV / sales
    5.30
    Capex intensity
    1.4%
    Revenue CAGR
    21.2%
    Profit CAGR
    35.5%

    Computed from filed statements, not filed themselves. A dash means an input was absent, and the score counts only the criteria that could actually be tested.

    Corporate actions

    • dividend
      ₹1.30

      Dividend - Rs 1.30 Per Share

      17 Jul 2026
      ex-date
    • dividend
      ₹1.20

      Dividend - Rs 1.20 Per Share

      25 Jul 2025
      ex-date
    • dividend
      Not available — not reported in this filing

      Dividend - Re 0.90 Per Share

      19 Jul 2024
      ex-date
    • dividend
      ₹5.00

      Special Interim Dividend - Rs 5 Per Share

      14 Feb 2024
      ex-date
    • dividend
      ₹1.20

      Dividend - Rs 1.20 Per Share

      21 Jul 2023
      ex-date
    • dividend
      Not available — not reported in this filing

      Dividend - Re 1 Per Sh

      21 Jul 2022
      ex-date
    • dividend
      ₹0.80

      Dividend - Rs 0.80 Per Share

      22 Jul 2021
      ex-date
    • dividend
      ₹0.55

      Annual General Meeting/Dividend - Rs 0.55 Per Share

      2 Sept 2020
      ex-date

    Company announcements

    Company Update
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    Written Transcript of Earnings Call held on 27th October, 2026.

    Company Update
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    Audio Recording of Earnings Call held on 27th October, 2026.

    Company Update
    Announcement under Regulation 30 (LODR)-Investor Presentation

    Investor Presentation for the quarter and half year ended 30th September 2026

    Result
    Unaudited Financial Results For The Quarter And Half Year Ended 30.09.2026

    Unaudited Financial Results for the quarter and half year ended 30.09.2026

    Board Meeting
    Board Meeting Outcome for Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Half-Year Ended 30Th September, 2026.

    Unaudited Financial Results (Standalone and Consolidated) for the quarter and half-year ended 30th September, 2026.

    Company Update
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    Intimation of Earnings Call with Investors and Analysts on Tuesday, 27th October, 2026

    Company Update
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    Intimation of Earnings Call with Investors and Analysts on Tuesday, 27th October, 2026

    Company Update
    Certificate Under Regulation 74(5) Of SEBI( Depositories Participants) Regulations, 2015.

    Certificate Under Regulation 74(5) of SEBI( Depositories Participants) Regulations, 2015

    Board MeetingPrice-sensitive
    Board Meeting Intimation for Intimation Of Schedule Of Board Meeting To Be Held On 26Th October, 2026.

    Sumitomo Chemical India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/10/2026 ,inter alia, to consider and approve Intimation of schedule ....

    Company Update
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    Intimation of Schedule of Institutional Investors/Analyst meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015

    Company Update
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    Intimation of Schedule of Institutional Investors and Analysts meeting to be held on Wednesday, 19th August, 2026

    AGM/EGMPrice-sensitive
    Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    Compliance under Regulation 44(3) of the SEBI (LODR) Regulations, 2015.

    Company Update
    Announcement under Regulation 30 (LODR)-Investor Presentation

    Investor Presentation on the financial results of the Company for the quarter ended 30th June, 2026

    AGM/EGMPrice-sensitive
    Shareholder Meeting / Postal Ballot-Outcome of AGM

    Proceedings of 26th Annual General Meeting.

    Result
    Integrated Filing (Financial) For The Quarter Ended 30Th June, 2026.

    Integrated Filing (Financial) for the quarter ended 30th June, 2026.

    Filed with BSE (scrip 542920); the last 45 days. Documents open at bseindia.com.

    Documents

    Earnings calls

    Credit ratings

    Documents open at BSE or the rating agency that issued them.

    Sourced from the company's NSE XBRL filing dated 26 Oct 2026 (unaudited). View the source filing. Figures are as filed and are not investment advice.

    FAQ

    Sumitomo Chemical India: common questions

    Answered from the figures on this page.

    Sumitomo Chemical India last traded at ₹334.25 (NSE, as of 18 Nov 2026). The last session moved it down 2.38%.

    Sumitomo Chemical India is valued at about ₹16,684 crore (NSE, as of 18 Nov 2026).

    Sumitomo Chemical India trades at a price-to-earnings ratio of 29.84 (NSE, as of 18 Nov 2026). The P/E compares the share price with earnings per share, so it is only comparable between companies in the same industry.

    Sumitomo Chemical India has traded between ₹310.85 and ₹572.05 over the past 52 weeks, to 18 Nov 2026. It is currently 9% of the way up that range.

    Sumitomo Chemical India (SUMICHEM) is classified under Chemicals on this site's screener.